CENTENE CORPORATION
CNC US15135B1017
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 33% | -1% | -7% | -21% | 2% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| London Sarah CEO |
25.50 USD |
19,230 Bought |
490,365 USD |
08/08/2025 | 08/08/2025 |
| Samuels Theodore R. Ii O |
27.62 USD |
9,000 Bought |
248,580 USD |
28/07/2025 | 28/07/2025 |
| Greco Thomas |
59.75 USD |
17,000 Bought |
1,015,750 USD |
18/12/2024 | 18/12/2024 |
| Blume Jessica L. O |
59.48 USD |
250 Bought |
14,870 USD |
16/12/2024 | 16/12/2024 |
| Dallas H James O |
59.01 USD |
1,693 Bought |
99,904 USD |
16/12/2024 | 16/12/2024 |
| Coughlin Christopher J O |
59.44 USD |
10,000 Bought |
594,400 USD |
16/12/2024 | 16/12/2024 |
| Samuels Theodore R. Ii O |
58.86 USD |
5,000 Bought |
294,300 USD |
13/12/2024 | 13/12/2024 |
| Asher Andrew Lynn CFO |
58.14 USD |
17,200 Bought |
1,000,008 USD |
13/11/2024 | 13/11/2024 |
| London Sarah CEO |
60.80 USD |
4,117 Bought |
250,314 USD |
08/11/2024 | 08/11/2024 |
| Coughlin Christopher J O |
76.75 USD |
878 Sold |
67,382 USD |
14/05/2024 | 14/05/2024 |